Search research articles
Contact Us
Filters
Showing results (21-30 of 48) with videos related to
Page
of 5
Sort By:
Cardiovascular Drugs and Therapy
|
April 1, 1990
Relationship between age and the cardiovascular response to meals
T C Fagan, K A Conrad, P V Mayshar, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1986
Antihypertensive and biochemical dose-response study of tripamide
T C Fagan, K A Conrad, S Lee, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1984
Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy
T C Fagan, C Sternleib, N Vlachakis, et al.
British Journal of Clinical Pharmacology
|
November 1, 1984
Stereoselective ring oxidation of propranolol in man
T Walle, U K Walle, M J Wilson, et al.
Chest
|
August 1, 1993
Sustained-release nicardipine in mild-to-moderate hypertension
T C Fagan, E D Tyler, M A Reitman, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1979
Propranolol glucuronide cumulation during long-term propranolol therapy: a proposed storage mechanism for propranolol
T Walle, E C Conradi, U K Walle, et al.
British Journal of Clinical Pharmacology
|
January 1, 1994
The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers
U K Walle, T C Fagan, M J Topmiller, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1980
4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol
T Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1978
The predictable relationship between plasma levels and dose during chronic propranolol therapy
T Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1979
Presystemic and systemic glucuronidation of propranolol
T Walle, T C Fagan, E C Conradi, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 48) with videos related to
Sort By:
Page
of 5
Cardiovascular Drugs and Therapy
|
April 1, 1990
Relationship between age and the cardiovascular response to meals
T C Fagan, K A Conrad, P V Mayshar, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1986
Antihypertensive and biochemical dose-response study of tripamide
T C Fagan, K A Conrad, S Lee, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1984
Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy
T C Fagan, C Sternleib, N Vlachakis, et al.
British Journal of Clinical Pharmacology
|
November 1, 1984
Stereoselective ring oxidation of propranolol in man
T Walle, U K Walle, M J Wilson, et al.
Chest
|
August 1, 1993
Sustained-release nicardipine in mild-to-moderate hypertension
T C Fagan, E D Tyler, M A Reitman, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1979
Propranolol glucuronide cumulation during long-term propranolol therapy: a proposed storage mechanism for propranolol
T Walle, E C Conradi, U K Walle, et al.
British Journal of Clinical Pharmacology
|
January 1, 1994
The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers
U K Walle, T C Fagan, M J Topmiller, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1980
4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol
T Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1978
The predictable relationship between plasma levels and dose during chronic propranolol therapy
T Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1979
Presystemic and systemic glucuronidation of propranolol
T Walle, T C Fagan, E C Conradi, et al.
Page
of 5